Vivos Therapeutics, Inc. Repayments of Long-Term Debt
Vivos Therapeutics, Inc. (VVOS) reported Repayments of Long-Term Debt of $25.00 thousand for the 12-month period ending 2021-12-31, per its 10-K filed 2023-03-30.
Discontinued › Cash Flow › Financing Activities
us-gaap:RepaymentsOfLongTermDebt · last filed 2023-03-30
- Vivos Therapeutics, Inc. repayments of long-term debt for the quarter ending 2021-12-31 was $0.00.
- Vivos Therapeutics, Inc. repayments of long-term debt for the quarter ending 2021-09-30 was $0.00.
- Vivos Therapeutics, Inc. repayments of long-term debt for the quarter ending 2021-06-30 was $0.00.
- Vivos Therapeutics, Inc. repayments of long-term debt for the quarter ending 2021-03-31 was $25.00K.
- Vivos Therapeutics, Inc. repayments of long-term debt for fiscal 2021 was $25.00K, a 66.67% decline from fiscal 2020.
- Vivos Therapeutics, Inc. repayments of long-term debt for fiscal 2020 was $75.00K, a 156.32% increase from fiscal 2019.
- Vivos Therapeutics, Inc. repayments of long-term debt for fiscal 2019 was $29.26K.
| Period end | Repayments of Long-term Debt 3 month | Repayments of Long-term Debt 6 month | Repayments of Long-term Debt 9 month | Repayments of Long-term Debt 12 month |
|---|---|---|---|---|
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $0.00 derived: sum of 2 quarters · filed 2023-03-30 | $0.00 derived: sum of 3 quarters · filed 2023-03-30 | $25.00K 10-K · filed 2023-03-30 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-12-20 | $0.00 derived: sum of 2 quarters · filed 2022-12-20 | $25.00K 10-Q · filed 2022-12-20 | |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q/A 3 month · filed 2022-12-20 | $25.00K 10-Q · filed 2022-12-20 | ||
| 2021-03-31 | $25.00K 10-Q/A · filed 2022-11-25 | |||
| 2020-12-31 | $75.00K 10-K · filed 2022-03-31 | |||
| 2019-12-31 | $29.26K 10-K · filed 2021-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |